PsyMed Ventures
PsyMed Ventures is a venture capital firm dedicated to investing in the future of mental and brain health. The firm focuses on funding and supporting founders who are revolutionizing brain and mental health through innovative neuroscience and frontier technologies. PsyMed Ventures aims to align healing, responsibility, and profitability, believing that psychedelic therapies will heal millions of people by treating the underlying causes of mental health conditions rather than just the symptoms.
Portfolio
Precision psychiatry drug development platform
#Precision psychiatry drug development
CRISPR for live biotherapeutics and bacterial products
#CRISPR for live biotherapeutics and bacterial products
Drug development platform with pipeline of 10+ programs for brain and mental health
#Drug development platform
Drug development platform focused on neurological and psychiatric disorders
#Drug development platform
Novel ketamine formulations for pain management and mental health disorders
#Novel ketamine formulations
Microbiome therapeutics platform for neurological disease
#Microbiome therapeutics platform
Creating the next generation of psychedelics to treat mental health and other CNS disorders
#Psychedelics
Non-hallucinogenic versions of psychedelic compounds with favorable safety and efficacy
#Psychedelic compounds
Next generation ketamine & psychedelic therapeutics
#Ketamine & psychedelic therapeutics
Clinical stage neuroscience biotech developing innovative new chemical entities
#Neuroscience biotech
Empowering mental health professionals to offer psychedelic-assisted therapy
#Psychedelic-assisted therapy
Patient management and data intelligence platform for psychedelic therapy
#Psychedelic therapy
Next generation psychedelic-inspired therapeutics for mental health conditions
#Psychedelic-inspired therapeutics
Non invasive neurostimulation and monitoring platform, starting with ADHD
#Neurostimulation and monitoring
Novel psychedelic treatments for patients with life-threatening illnesses
#Psychedelic treatments